Lipoprotein Interactions with the Arterial Wall: Pro- vs. Anti-Atherogenic Effects

被引：0
|
作者：
Mullick, Adam Emile [1 ]
机构：
[1] Univ Calif Davis, Davis, CA 95616 USA
来源：
METABOLIC SYNDROME AND RELATED DISORDERS | 2003年 / 1卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：316 / 316
页数：1
相关论文
共 50 条
  • [21] Anti-atherogenic effects of high-density lipoprotein on nitric oxide synthesis in the endothelium
    Andrews, Karen L.
    Moore, Xiao L.
    Chin-Dusting, Jaye P. F.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (07): : 736 - 742
  • [22] Hyperinsulinemia has anti-atherogenic effects in vivo
    Kim, T
    Chan, K
    Huynh, N
    Lam, L
    Uchino, H
    Bendeck, MP
    Giacca, A
    DIABETES, 2002, 51 : A158 - A158
  • [23] A Review of the Cardiovascular and Anti-Atherogenic Effects of Ghrelin
    Rizzo, Manfredi
    Rizvi, Ali A.
    Sudar, Emina
    Soskic, Sanja
    Obradovic, Milan
    Montalto, Giuseppe
    Boutjdir, Mohamed
    Mikhailidis, Dimitri P.
    Isenovic, Esma R.
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (27) : 4953 - 4963
  • [24] Cell-mediated lipoprotein transport: A novel anti-atherogenic concept
    Bovenberg, S. A.
    Alipour, A.
    Elte, J. W. F.
    Rietveld, A. P.
    Janssen, J. W.
    van de Geijn, G. J.
    Njo, T. N.
    van Mechelen, R.
    Martinez Hervas, S.
    Cabezas, M. Castro
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (01) : 25 - 29
  • [25] ANTI-ATHEROGENIC PROPERTIES OF TRISUN VS SUNFLOWER OIL IN THE HAMSTER
    COURTEMANCHE, K
    ROGERS, E
    SACCHIERO, R
    LAITINEN, L
    LIANG, S
    NICOLOSI, R
    FASEB JOURNAL, 1993, 7 (04): : A794 - A794
  • [26] HIGH-DENSITY LIPOPROTEIN MAY NOT BE ANTI-ATHEROGENIC AFTER ALL
    KINNUNEN, PKJ
    LANCET, 1979, 2 (8132): : 34 - 35
  • [27] The anti-carcinogenic and anti-atherogenic effects of lycopene: a review
    Omoni, AO
    Aluko, RE
    TRENDS IN FOOD SCIENCE & TECHNOLOGY, 2005, 16 (08) : 344 - 350
  • [28] ApolipoproteinA1-75 G/A (MI-) polymorphism and lipoprotein(a);: Anti- vs. pro-atherogenic properties
    Albahrani, Ali I.
    Jannete, Usher J.
    Alkindi, Mohammed
    Marks, Eileen
    Ranganath, L.
    Al-Yahyaee, Said
    LIPIDS IN HEALTH AND DISEASE, 2007, 6 (1)
  • [29] Back to basics: The effects of block vs. interleaved trial administration on pro- and anti-saccade performance
    Zeligman, Liran
    Zivotofsky, Ari Z.
    PLOS ONE, 2017, 12 (02):
  • [30] Anti-atherogenic effects of fibrates in type 2 diabetes
    Barter, P
    CURRENT CONTROLLED TRIALS IN CARDIOVASCULAR MEDICINE, 2001, 2 (05): : 218 - 220
12345